GLP-1 analogs (Theratechnologies/ALZA)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGLP-1 analogs (Theratechnologies/ALZA)
Drug Alias NameLAP-stabilized GLP-1 analogs (Theratechnologies/ALZA)ThGLP-1 Macroflux (Theratechnologies/ALZA)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin release stimulantsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptorInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheratechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheratechnologies IncAlza Corp
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A